Cargando…
CRISPR/Cas9-generated p47(phox)-deficient cell line for Chronic Granulomatous Disease gene therapy vector development
Development of gene therapy vectors requires cellular models reflecting the genetic background of a disease thus allowing for robust preclinical vector testing. For human p47(phox)-deficient chronic granulomatous disease (CGD) vector testing we generated a cellular model using clustered regularly in...
Autores principales: | Wrona, Dominik, Siler, Ulrich, Reichenbach, Janine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347011/ https://www.ncbi.nlm.nih.gov/pubmed/28287132 http://dx.doi.org/10.1038/srep44187 |
Ejemplares similares
-
Novel Diagnostic Tool for p47(phox)-Deficient Chronic Granulomatous Disease Patient and Carrier Detection
por: Wrona, Dominik, et al.
Publicado: (2019) -
The p47phox mouse knock-out model of chronic granulomatous disease
Publicado: (1995) -
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47(phox)-Deficient Chronic Granulomatous Disease
por: Schejtman, Andrea, et al.
Publicado: (2021) -
CRISPR-Directed Therapeutic Correction at the NCF1 Locus Is Challenged by Frequent Incidence of Chromosomal Deletions
por: Wrona, Dominik, et al.
Publicado: (2020) -
Lentiviral gene therapy rescues p47(phox) chronic granulomatous disease and the ability to fight Salmonella infection in mice
por: Schejtman, Andrea, et al.
Publicado: (2020)